PD-068 An exploratory analysis of a phase III study in patients with advanced non-small cell lung cancer (NSCLC): The impact of first-line gemcitabine and platinum therapy on the outcome of second-line therapy with pemetrexed or docetaxel
Bunn, P., Rosell, R., Fossella, F., Perry, M., Stahel, R., Barata, F., Nguyen, B., Paul, S., Hanna, N.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80401-5
Date:
July, 2005
File:
PDF, 142 KB
english, 2005